Home › Leading Cancer Centers To Present Clinical Utility Data for Guardant360A At ASCO
 

Keywords :   


Leading Cancer Centers To Present Clinical Utility Data for Guardant360A At ASCO

2015-05-27 13:10:29| Logistics - Topix.net

This toolset includes: Tumor Response Map: A powerful new visual language of tumor genomics, helping to unify the representation of tumor genomics, heterogeneity and clinical response over time. Enhanced Guardant360 Report: By using the Tumor Response Map and the alteration-specific trend line, the report offers a visual representation of changes and trends in patients' sequential tests, allowing them to quickly see a summary of all detected somatic cfDNA alterations and their quantitative burden, along with available therapeutics and clinical trials.

Tags: data present leading cancer

Category:Transportation and Logistics

Latest from this category

All news
24.04Atlantic Tropical Weather Outlook
Transportation and Logistics »
29.04New law aims to protect devices from hackers
28.04National Coalition to End Period Poverty Launched
28.04PZ Cussons To Sell St. Tropez & Aveda Launches Curl Care Line
28.04Beauty Enthusiasts Eye Burgundy Mascara
28.04Distinctive Assets Distributes Mother\'s Day in Hollywood Celebrity Gift Boxes
28.04Musk in China to discuss full self driving - reports
28.04Weekly Recap: U.K. Government Announces Plastic Wipes Ban; Unicharm Starts Selling Recycled Diaper
28.04'Buying a first home is harder when you're single'
More »